The Latest Breaking News from Insulet

AMD stock surged past a new buy point in today's stock market action, while Chipotle boasts rising profit estimates.

The Dow Jones Industrial Average rose Wednesday on a cool inflation report and weak retail sales. Tesla stock raced higher, looking to add to Tuesday's surge.

The Dow Jones dropped Tuesday ahead of more key inflation data due out Wednesday. Goldman Sachs fell on an earnings miss.

Futures fell after the market rally cleared resistance last week. Time to act, carefully. Tesla China sales rose post-price cuts.

Dow giant UnitedHealth is among 5 stocks holding key support while the overall market weakens.

The market rally started strong, but sold off hard in a big outside week. Leading stocks tumbled. Tesla plunged, but is trying to bounce. Here's what to do.

Diabetes devices maker Insulet is the IBD Stock Of The Day as PODD stock hovers in a buy zone near its 21-day moving average.

Upgrades

Neurocrine Biosciences leads five medical stocks near key support levels as the health care sector shows resilience in a sickly market.

Several stocks flashed buy signals as the market rallied heading into Fed chief Powell's speech. Here's what to expect.

The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Insulet shares traded in a range of $260.13 to $266.73 on day volume of 200.86 thousand shares…